Van Den Eynde; Benoit

Patent Applications and Registrations

Patent applications and USPTO patent grants for Van Den Eynde; Benoit.The latest application filed is for "recombinant adenylate cyclase toxin of bordetella induces t cell responses against tumoral antigens".

Company Profile

0.21.11

Van Den Eynde; Benoit - Genval FR
Van Den Eynde; Benoit - Brussels BE
van den Eynde; Benoit - Brussles BE
van den Eynde; Benoit - Rixensart BE

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Recombinant Adenylate Cyclase Toxin Of Bordetella Induces T Cell Responses Against Tumoral Antigens App 20140227323 - DADAGLIO; Gilles ; et al.	2014-08-14
MAGE-C2 antigenic peptides and uses thereof Grant 8,143,011 - Ma , et al. March 27, 2	2012-03-27
Mage-c2 Antigenic Peptides And Uses Thereof App 20110305722 - MA; Wenbin ; et al.	2011-12-15
Trytophan Catabolism In Cancer Treatment And Diagnosis App 20110159017 - Van Den Eynde; Benoit ; et al.	2011-06-30
Ido Inhibitors And Therapeutic Uses Thereof App 20110112282 - Roehrig; Ute ; et al.	2011-05-12
Isolated tumor rejection antigen precursor proteins MAGE-2 and MAGE-3 Grant 7,923,534 - Boon , et al. April 12, 2	2011-04-12
Recombinant Adenylate Cyclase Toxin Of Bordetella Induces T Cell Responses Against Tumoral Antigens App 20100310594 - Dadaglio; Gilles ; et al.	2010-12-09
Method For The Determination And The Classification Of Rheumatic Conditions App 20100273671 - Lauwerys; Bernard ; et al.	2010-10-28
MAGE-C2 antigenic peptides and uses therefor App 20090233315 - Ma; Wenbin ; et al.	2009-09-17
Isolated GAGE-7B and 8 proteins Grant 7,572,885 - De Backer , et al. August 11, 2	2009-08-11
MAGE-C2 antigenic peptides and uses thereof Grant 7,547,517 - Ma , et al. June 16, 2	2009-06-16
Isolated proteins MAGE-4 and MAGE-41 Grant 7,495,074 - Guagler , et al. February 24, 2	2009-02-24
Nucleic acid molecules encoding the MAGE-1 tumor rejection antigen precursor Grant RE40,089 - Boon-Falleur , et al. February 19, 2	2008-02-19
Isolated GAGE-7B and 8 proteins App 20070219349 - Backer; Olivier De ; et al.	2007-09-20
Isolated nucleic acid molecules coding for tumor rejection antigen precursor MAGE-4 and 41 and uses thereof Grant 7,199,231 - Guagler , et al. April 3, 2	2007-04-03
Recombinant adenylate cyclase toxin of Bordetella induces T cell responses against tumoral antigens App 20050271679 - Dadaglio, Gilles ; et al.	2005-12-08
Isolated nucleic acid molecules coding for tumor rejection antigen precursor MAGE-6 and uses thereof Grant 6,946,289 - Guagler , et al. September 20, 2	2005-09-20
Isolated nucleic acid molecules which encode GAGE genes and uses thereof Grant 6,939,707 - van der Bruggen , et al. September 6, 2	2005-09-06
Mage-A12 antigenic peptides and uses thereof Grant 6,897,288 - Heidecker , et al. May 24, 2	2005-05-24
MAGE-C2 antigenic peptides and uses thereof App 20040214779 - Ma, Wenbin ; et al.	2004-10-28
Isolated peptides which bind to HLA-B35 molecules, larger peptides which contain these, nucleic acid molecules encoding peptides, and uses thereof Grant 6,667,037 - Ooms , et al. December 23, 2	2003-12-23
Structurally modified peptides that are resistant to peptidase degradation Grant 6,623,740 - Gairin , et al. September 23, 2	2003-09-23
Methods for diagnosing a disorder by assaying for MAGE-3 Grant 6,599,699 - Guagler , et al. July 29, 2	2003-07-29
Method for screening for cancer using binders for MAGE related peptides and complexes of the peptide and HLA molecules Grant 6,379,901 - Boon-Falleur , et al. April 30, 2	2002-04-30
Isolated nonapeptides presented by HLA molecules, and uses thereof Grant 6,222,012 - Boon-Falleur , et al. April 24, 2	2001-04-24
Isolated RAGE-1 derived peptides which complex with HLA-B7 molecules and uses thereof Grant 5,939,526 - Gaugler , et al. August 17, 1	1999-08-17
Tumor rejection antigen precursors, tumor rejection antigens and uses thereof Grant 5,925,729 - Boon , et al. July 20, 1	1999-07-20
Isolated cytolytic T cells specific for complexes of MAGE related peptides and HLA molecules Grant 5,695,994 - Boon-Falleur , et al. December 9, 1	1997-12-09
Isolated peptides derived from tumor rejection antigens, and their use Grant 5,648,226 - Van den Eynde , et al. July 15, 1	1997-07-15
Isolated nucleic acid molecules which encode MAGE derived nonapeptides Grant 5,462,871 - Boon-Falleur , et al. October 31, 1	1995-10-31
Nucleotide sequence encoding the tumor rejection antigen precursor, MAGE-1 Grant 5,342,774 - Boon , et al. August 30, 1	1994-08-30

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.